📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Abolishing ß-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists (2023)

First Author: Hinds C

Attributed to: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.15288

PubMed Identifier: 37795639

Publication URI: http://europepmc.org/abstract/MED/37795639

Type: Journal Article/Review

Parent Publication: Diabetes, Obesity and Metabolism

Issue: 1

ISSN: 1462-8902